NVO

Trade of the Day: Novo Nordisk (NVO)

Obesity-related disease is spreading across the world -- and traders should consider the pharmaceutical companies that will grow because of that trend. More 

3 Ways to Trade Diabetes Treatment

The treatment of diabetes continues to be a huge boon to drug companies. Here is a look att three potential stock picks for the space. More 

48 Ways to Prepare for Earnings Season

Second-quarter earnings season is just around the corner and it's probably not going to turn any heads. Here's a preview of what to expect More 

New Obesity Drug Could Launch in U.S. Before 2015

Danish drug-maker Novo Nordisk says its anti-obesity treatment liraglutide could become available for sale in the U.S. by the end of 2014. More 

AAPL Is Still Sour; Look for New Opportunities

The markets are in the middle of a strong rally, and a resurgent Apple is helping to lead the way. I still think it's a stock to sell. More 

3 Call Contenders in Pharmaceuticals

These pharmaceutical stocks are doing something right--all have shown up as strong buys on my Power Stock scanner. More 

6 Call Contenders Releasing Earnings

These bullish stocks are all reporting this week -- why not take advantage with call options? More